GeneDx Holdings Corp (NASDAQ:WGS) has a beta value of 2.01 and has seen 2.36 million shares traded in the last trading session. The company, currently valued at $2.27B, closed the last trade at $79.71 per share which meant it gained $12.71 on the day or 18.97%% during that session. The WGS stock price is -47.72% off its 52-week high price of $117.75 and 68.75% above the 52-week low of $24.91.
The consensus among analysts is that GeneDx Holdings Corp (WGS) is Buy stock at the moment, with a recommendation rating of 1.33. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 3 have rated it as a Hold, with 3 advising it as a Buy. 0 have rated the stock as Underweight.
GeneDx Holdings Corp (NASDAQ:WGS) trade information
Sporting 18.97%% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the WGS stock price touched $79.71 or saw a rise of 0.98%. Year-to-date, GeneDx Holdings Corp shares have moved 188.80%, while the 5-day performance has seen it change 23.45%. Over the past 30 days, the shares of GeneDx Holdings Corp (NASDAQ:WGS) have changed 17.60%.
Wall Street analysts have a consensus price target for the stock at $39.5, which means that the shares’ value could drop -101.8% from current levels. The projected low price target is $21.0 while the price target rests at a high of $70.0. In that case, then, we find that the current price level is 12.18% off the targeted high while a plunge would see the stock lose 73.65% from current levels.
GeneDx Holdings Corp (WGS) estimates and forecasts
The company’s shares have gained 0.64% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 96.65% over the past 5 years. Earnings growth for 2025 is a modest 319.52% while over the next 5 years, the company’s earnings are expected to increase by 120.75%.
WGS Dividends
GeneDx Holdings Corp is expected to release its next earnings report in July this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
GeneDx Holdings Corp (NASDAQ:WGS)’s Major holders
The top two institutional holders are CASDIN CAPITAL, LLC with over 3.53 million shares worth more than $92.18 million. As of 2024-06-30, CASDIN CAPITAL, LLC held 13.2482% of shares outstanding.
The other major institutional holder is CORVEX MANAGEMENT LP, with the holding of over 2.47 million shares as of 2024-06-30. The firm’s total holdings are worth over $64.66 million and represent 9.2937% of shares outstanding.
